In the Viewpoint titled “Remote Patient Monitoring During COVID-19: An Unexpected Patient Safety Benefit,”1 published in the March 22, 2022, issue of JAMA, and in a related Letter in Reply titled “Remote Patient Monitoring During COVID-19—Reply,”2 published in the July 19, 2022, issue of JAMA, the authors’ conflict of interest disclosures were incomplete. For the Viewpoint, the disclosures should have read as follows: “Dr Pronovost reported grants from Masimo (collection of data on remote monitoring) during the conduct of the study. Ms Cole reported receipt of grants from Masimo (analysis of home-monitoring data). Dr Hughes reported receipt of a grant from Masimo (analysis of home-monitoring data).” For the Letter in Reply, the disclosures should have read as follows: “Dr Pronovost reported grants from Masimo (collection of data on remote monitoring) during the conduct of the study. Ms Cole reported receipt of grants from Masimo (analysis of home-monitoring data) and from the Federal Communications Commission (FCC) Coronavirus Aid, Relief, and Economic Security (CARES) Act (for purchase of home-monitoring devices). Dr Hughes reported receipt of a grant from Masimo (analysis of home-monitoring data).” These articles have been corrected online.
References
- 1.Pronovost PJ, Cole MD, Hughes RM. Remote patient monitoring during COVID-19: an unexpected patient safety benefit. JAMA. 2022;327(12):1125-1126. doi: 10.1001/jama.2022.2040 [DOI] [PubMed] [Google Scholar]
- 2.Pronovost PJ, Cole MD, Hughes RM. Remote patient monitoring during COVID-19—reply. JAMA. 2022;328(3):303-304. doi: 10.1001/jama.2022.8878 [DOI] [PubMed] [Google Scholar]
